COPD 및 천식용 기기 시장 : 제품 유형, 용도, 최종사용자, 유통 채널별 - 세계 예측(2025-2030년)

The COPD & Asthma Devices Market was valued at USD 35.33 billion in 2023, expected to reach USD 37.45 billion in 2024, and is projected to grow at a CAGR of 5.93%, to USD 52.90 billion by 2030.

The COPD and asthma devices market encompasses medical devices and equipment designed for the diagnosis, treatment, and management of Chronic Obstructive Pulmonary Disease (COPD) and asthma. This includes inhalers, nebulizers, oxygen concentrators, and spirometry devices, which are essential for clinical and home-based settings. The necessity of these devices stems from the increasing prevalence of respiratory diseases due to factors like pollution, smoking, and an aging population. These devices are pivotal in efficiently administering medications, monitoring respiratory conditions, and improving the quality of life for patients. The growing awareness about respiratory health and advancements in medical technology drive demand in both developed and developing markets. Key growth factors include technological innovations such as smart inhalers and portable nebulizers, increasing healthcare expenditure, and supportive government policies promoting respiratory care. Latest opportunities lie in the integration of digital health technologies, which offer enhanced patient adherence and monitoring through apps and IoT-enabled devices. Manufacturers can capitalize on this by investing in R&D to create more user-friendly and connected devices that cater to tech-savvy patients. However, the market faces challenges such as high costs of advanced devices, stringent regulatory approvals, and limited access in lower-income regions. Additionally, the disparity in healthcare infrastructure could hinder market growth in emerging economies. Companies focusing on innovation must consider cost-effective manufacturing processes and seek partnerships to expand market reach to overcome these barriers. Research should also target enhancing device effectiveness and reducing side effects to meet patient-specific needs. The market remains competitive, with consolidation trends as companies seek to expand their product portfolios through mergers and acquisitions. Overall, the industry continues evolving, with ample scope for development in patient-centered and digital innovations, which present lucrative opportunities for growth in the COPD and asthma devices market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving COPD & Asthma Devices Market

The COPD & Asthma Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Government initiatives and policies supporting respiratory disease management and treatment
  • Emerging markets creating new opportunities for respiratory device manufacturers through enhanced healthcare access
  • Improved patient adherence to respiratory therapies driven by user-friendly and portable device designs
  • Rising environmental pollution exacerbating respiratory conditions and increasing demand for treatment devices
• Market Restraints
  • Lack of standardization in COPD & asthma device manufacturing affecting product consistency
  • Challenges in educating healthcare providers about the latest COPD & asthma device advancements
• Market Opportunities
  • Rise of personalized medicine approaches in COPD and asthma treatment protocols
  • Growth in patient education and self-management programs to reduce asthma-related hospitalizations
  • Innovative drug delivery systems enhancing medication adherence in COPD treatments
• Market Challenges
  • Complications in ensuring patient adherence and compliance with prescribed treatment regimens
  • Limited healthcare access in rural and underserved areas

Porter's Five Forces: A Strategic Tool for Navigating the COPD & Asthma Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the COPD & Asthma Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the COPD & Asthma Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the COPD & Asthma Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the COPD & Asthma Devices Market

A detailed market share analysis in the COPD & Asthma Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the COPD & Asthma Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the COPD & Asthma Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the COPD & Asthma Devices Market

A strategic analysis of the COPD & Asthma Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the COPD & Asthma Devices Market, highlighting leading vendors and their innovative profiles. These include 3M Health Care, Aerogen, Air Liquide Healthcare, Becton, Dickinson and Company, Chart Industries, Drive DeVilbiss Healthcare, Fisher & Paykel Healthcare, Getinge, GF Health Products, Inc., Hamilton Medical, Invacare Corporation, Koninklijke Philips N.V., Medtronic, Nihon Kohden Corporation, PARI Medical Holding, ResMed, Smiths Medical, SunMed, and Teleflex Incorporated.

Market Segmentation & Coverage

This research report categorizes the COPD & Asthma Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product Type, market is studied across Accessories, Inhalers, and Nebulizers. The Accessories is further studied across Actuators, Dry Powder Inhaler Rotacaps & Cartridges, and Spacers. The Inhalers is further studied across Dry Powder Inhalers (DPI), Metered-Dose Inhalers (MDI), and Soft Mist Inhalers. The Nebulizers is further studied across Jet Nebulizers, Mesh Nebulizers, and Ultrasonic Nebulizers.
• Based on Application, market is studied across Asthma and Chronic Obstructive Pulmonary Disease (COPD). The Asthma is further studied across Allergic Asthma, Exercise-Induced Asthma, and Non-Allergic Asthma. The Chronic Obstructive Pulmonary Disease (COPD) is further studied across Chronic Bronchitis and Emphysema.
• Based on End-User, market is studied across Ambulatory Surgical Centers, Homecare Settings, Hospitals & Clinics, and Specialty Clinics.
• Based on Distribution Channel, market is studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Government initiatives and policies supporting respiratory disease management and treatment
    • 5.1.1.2. Emerging markets creating new opportunities for respiratory device manufacturers through enhanced healthcare access
    • 5.1.1.3. Improved patient adherence to respiratory therapies driven by user-friendly and portable device designs
    • 5.1.1.4. Rising environmental pollution exacerbating respiratory conditions and increasing demand for treatment devices
  • 5.1.2. Restraints
    • 5.1.2.1. Lack of standardization in COPD & asthma device manufacturing affecting product consistency
    • 5.1.2.2. Challenges in educating healthcare providers about the latest COPD & asthma device advancements
  • 5.1.3. Opportunities
    • 5.1.3.1. Rise of personalized medicine approaches in COPD and asthma treatment protocols
    • 5.1.3.2. Growth in patient education and self-management programs to reduce asthma-related hospitalizations
    • 5.1.3.3. Innovative drug delivery systems enhancing medication adherence in COPD treatments
  • 5.1.4. Challenges
    • 5.1.4.1. Complications in ensuring patient adherence and compliance with prescribed treatment regimens
    • 5.1.4.2. Limited healthcare access in rural and underserved areas
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. COPD & Asthma Devices Market, by Product Type

• 6.1. Introduction
• 6.2. Accessories
  • 6.2.1. Actuators
  • 6.2.2. Dry Powder Inhaler Rotacaps & Cartridges
  • 6.2.3. Spacers
• 6.3. Inhalers
  • 6.3.1. Dry Powder Inhalers (DPI)
  • 6.3.2. Metered-Dose Inhalers (MDI)
  • 6.3.3. Soft Mist Inhalers
• 6.4. Nebulizers
  • 6.4.1. Jet Nebulizers
  • 6.4.2. Mesh Nebulizers
  • 6.4.3. Ultrasonic Nebulizers

7. COPD & Asthma Devices Market, by Application

• 7.1. Introduction
• 7.2. Asthma
  • 7.2.1. Allergic Asthma
  • 7.2.2. Exercise-Induced Asthma
  • 7.2.3. Non-Allergic Asthma
• 7.3. Chronic Obstructive Pulmonary Disease (COPD)
  • 7.3.1. Chronic Bronchitis
  • 7.3.2. Emphysema

8. COPD & Asthma Devices Market, by End-User

• 8.1. Introduction
• 8.2. Ambulatory Surgical Centers
• 8.3. Homecare Settings
• 8.4. Hospitals & Clinics
• 8.5. Specialty Clinics

9. COPD & Asthma Devices Market, by Distribution Channel

• 9.1. Introduction
• 9.2. Hospital Pharmacies
• 9.3. Online Pharmacies
• 9.4. Retail Pharmacies

10. Americas COPD & Asthma Devices Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific COPD & Asthma Devices Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa COPD & Asthma Devices Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 3M Health Care
• 2. Aerogen
• 3. Air Liquide Healthcare
• 4. Becton, Dickinson and Company
• 5. Chart Industries
• 6. Drive DeVilbiss Healthcare
• 7. Fisher & Paykel Healthcare
• 8. Getinge
• 9. GF Health Products, Inc.
• 10. Hamilton Medical
• 11. Invacare Corporation
• 12. Koninklijke Philips N.V.
• 13. Medtronic
• 14. Nihon Kohden Corporation
• 15. PARI Medical Holding
• 16. ResMed
• 17. Smiths Medical
• 18. SunMed
• 19. Teleflex Incorporated